Targeted Protein Degradation Market - Global Outlook and Forecast 2021-2027

March 2021 | 107 pages | ID: TF88A37DD136EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Targeted Protein Degradation in Global, including the following market information:

Global Targeted Protein Degradation Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Targeted Protein Degradation market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Targeted Protein Degradation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Targeted Protein Degradation Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Targeted Protein Degradation Market Segment Percentages, By Type, 2020 (%)

• Oral
• Intravenous
• Others

China Targeted Protein Degradation Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Targeted Protein Degradation Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Research Institute

Global Targeted Protein Degradation Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Targeted Protein Degradation Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Targeted Protein Degradation Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Targeted Protein Degradation Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• 5AM Venture Management LLC
• AbbVie Inc
• Almac Group
• Amgen Inc.
• Bayer AG
• Biogen Inc.
• C4 Therapeutics
• Cosmo Bio USA
• Covance Inc
• Eli Lilly and Company
• Gilead Sciences, Inc
• GlaxoSmithKline plc
• Merck KGaA
• Mission Therapeutics
• Novartis AG
• Pfizer Inc
• Promega

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Targeted Protein Degradation Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Targeted Protein Degradation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TARGETED PROTEIN DEGRADATION OVERALL MARKET SIZE

2.1 Global Targeted Protein Degradation Market Size: 2021 VS 2027
2.2 Global Targeted Protein Degradation Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Targeted Protein Degradation Players in Global Market
3.2 Top Global Targeted Protein Degradation Companies Ranked by Revenue
3.3 Global Targeted Protein Degradation Revenue by Companies
3.4 Top 3 and Top 5 Targeted Protein Degradation Companies in Global Market, by Revenue in 2020
3.5 Global Companies Targeted Protein Degradation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Protein Degradation Players in Global Market
  3.6.1 List of Global Tier 1 Targeted Protein Degradation Companies
  3.6.2 List of Global Tier 2 and Tier 3 Targeted Protein Degradation Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Targeted Protein Degradation Market Size Markets, 2021 & 2027
  4.1.2 Oral
  4.1.3 Intravenous
  4.1.4 Others
4.2 By Type - Global Targeted Protein Degradation Revenue & Forecasts
  4.2.1 By Type - Global Targeted Protein Degradation Revenue, 2016-2021
  4.2.2 By Type - Global Targeted Protein Degradation Revenue, 2022-2027
  4.2.3 By Type - Global Targeted Protein Degradation Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Targeted Protein Degradation Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Research Institute
5.2 By Application - Global Targeted Protein Degradation Revenue & Forecasts
  5.2.1 By Application - Global Targeted Protein Degradation Revenue, 2016-2021
  5.2.2 By Application - Global Targeted Protein Degradation Revenue, 2022-2027
  5.2.3 By Application - Global Targeted Protein Degradation Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Targeted Protein Degradation Market Size, 2021 & 2027
6.2 By Region - Global Targeted Protein Degradation Revenue & Forecasts
  6.2.1 By Region - Global Targeted Protein Degradation Revenue, 2016-2021
  6.2.2 By Region - Global Targeted Protein Degradation Revenue, 2022-2027
  6.2.3 By Region - Global Targeted Protein Degradation Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Targeted Protein Degradation Revenue, 2016-2027
  6.3.2 US Targeted Protein Degradation Market Size, 2016-2027
  6.3.3 Canada Targeted Protein Degradation Market Size, 2016-2027
  6.3.4 Mexico Targeted Protein Degradation Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Targeted Protein Degradation Revenue, 2016-2027
  6.4.2 Germany Targeted Protein Degradation Market Size, 2016-2027
  6.4.3 France Targeted Protein Degradation Market Size, 2016-2027
  6.4.4 U.K. Targeted Protein Degradation Market Size, 2016-2027
  6.4.5 Italy Targeted Protein Degradation Market Size, 2016-2027
  6.4.6 Russia Targeted Protein Degradation Market Size, 2016-2027
  6.4.7 Nordic Countries Targeted Protein Degradation Market Size, 2016-2027
  6.4.8 Benelux Targeted Protein Degradation Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Targeted Protein Degradation Revenue, 2016-2027
  6.5.2 China Targeted Protein Degradation Market Size, 2016-2027
  6.5.3 Japan Targeted Protein Degradation Market Size, 2016-2027
  6.5.4 South Korea Targeted Protein Degradation Market Size, 2016-2027
  6.5.5 Southeast Asia Targeted Protein Degradation Market Size, 2016-2027
  6.5.6 India Targeted Protein Degradation Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Targeted Protein Degradation Revenue, 2016-2027
  6.6.2 Brazil Targeted Protein Degradation Market Size, 2016-2027
  6.6.3 Argentina Targeted Protein Degradation Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Targeted Protein Degradation Revenue, 2016-2027
  6.7.2 Turkey Targeted Protein Degradation Market Size, 2016-2027
  6.7.3 Israel Targeted Protein Degradation Market Size, 2016-2027
  6.7.4 Saudi Arabia Targeted Protein Degradation Market Size, 2016-2027
  6.7.5 UAE Targeted Protein Degradation Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 5AM Venture Management LLC
  7.1.1 5AM Venture Management LLC Corporate Summary
  7.1.2 5AM Venture Management LLC Business Overview
  7.1.3 5AM Venture Management LLC Targeted Protein Degradation Major Product Offerings
  7.1.4 5AM Venture Management LLC Targeted Protein Degradation Revenue in Global (2016-2021)
  7.1.5 5AM Venture Management LLC Key News
7.2 AbbVie Inc
  7.2.1 AbbVie Inc Corporate Summary
  7.2.2 AbbVie Inc Business Overview
  7.2.3 AbbVie Inc Targeted Protein Degradation Major Product Offerings
  7.2.4 AbbVie Inc Targeted Protein Degradation Revenue in Global (2016-2021)
  7.2.5 AbbVie Inc Key News
7.3 Almac Group
  7.3.1 Almac Group Corporate Summary
  7.3.2 Almac Group Business Overview
  7.3.3 Almac Group Targeted Protein Degradation Major Product Offerings
  7.3.4 Almac Group Targeted Protein Degradation Revenue in Global (2016-2021)
  7.3.5 Almac Group Key News
7.4 Amgen Inc.
  7.4.1 Amgen Inc. Corporate Summary
  7.4.2 Amgen Inc. Business Overview
  7.4.3 Amgen Inc. Targeted Protein Degradation Major Product Offerings
  7.4.4 Amgen Inc. Targeted Protein Degradation Revenue in Global (2016-2021)
  7.4.5 Amgen Inc. Key News
7.5 Bayer AG
  7.5.1 Bayer AG Corporate Summary
  7.5.2 Bayer AG Business Overview
  7.5.3 Bayer AG Targeted Protein Degradation Major Product Offerings
  7.5.4 Bayer AG Targeted Protein Degradation Revenue in Global (2016-2021)
  7.5.5 Bayer AG Key News
7.6 Biogen Inc.
  7.6.1 Biogen Inc. Corporate Summary
  7.6.2 Biogen Inc. Business Overview
  7.6.3 Biogen Inc. Targeted Protein Degradation Major Product Offerings
  7.6.4 Biogen Inc. Targeted Protein Degradation Revenue in Global (2016-2021)
  7.6.5 Biogen Inc. Key News
7.7 C4 Therapeutics
  7.7.1 C4 Therapeutics Corporate Summary
  7.7.2 C4 Therapeutics Business Overview
  7.7.3 C4 Therapeutics Targeted Protein Degradation Major Product Offerings
  7.4.4 C4 Therapeutics Targeted Protein Degradation Revenue in Global (2016-2021)
  7.7.5 C4 Therapeutics Key News
7.8 Cosmo Bio USA
  7.8.1 Cosmo Bio USA Corporate Summary
  7.8.2 Cosmo Bio USA Business Overview
  7.8.3 Cosmo Bio USA Targeted Protein Degradation Major Product Offerings
  7.8.4 Cosmo Bio USA Targeted Protein Degradation Revenue in Global (2016-2021)
  7.8.5 Cosmo Bio USA Key News
7.9 Covance Inc
  7.9.1 Covance Inc Corporate Summary
  7.9.2 Covance Inc Business Overview
  7.9.3 Covance Inc Targeted Protein Degradation Major Product Offerings
  7.9.4 Covance Inc Targeted Protein Degradation Revenue in Global (2016-2021)
  7.9.5 Covance Inc Key News
7.10 Eli Lilly and Company
  7.10.1 Eli Lilly and Company Corporate Summary
  7.10.2 Eli Lilly and Company Business Overview
  7.10.3 Eli Lilly and Company Targeted Protein Degradation Major Product Offerings
  7.10.4 Eli Lilly and Company Targeted Protein Degradation Revenue in Global (2016-2021)
  7.10.5 Eli Lilly and Company Key News
7.11 Gilead Sciences, Inc
  7.11.1 Gilead Sciences, Inc Corporate Summary
  7.11.2 Gilead Sciences, Inc Business Overview
  7.11.3 Gilead Sciences, Inc Targeted Protein Degradation Major Product Offerings
  7.11.4 Gilead Sciences, Inc Targeted Protein Degradation Revenue in Global (2016-2021)
  7.11.5 Gilead Sciences, Inc Key News
7.12 GlaxoSmithKline plc
  7.12.1 GlaxoSmithKline plc Corporate Summary
  7.12.2 GlaxoSmithKline plc Business Overview
  7.12.3 GlaxoSmithKline plc Targeted Protein Degradation Major Product Offerings
  7.12.4 GlaxoSmithKline plc Targeted Protein Degradation Revenue in Global (2016-2021)
  7.12.5 GlaxoSmithKline plc Key News
7.13 Merck KGaA
  7.13.1 Merck KGaA Corporate Summary
  7.13.2 Merck KGaA Business Overview
  7.13.3 Merck KGaA Targeted Protein Degradation Major Product Offerings
  7.13.4 Merck KGaA Targeted Protein Degradation Revenue in Global (2016-2021)
  7.13.5 Merck KGaA Key News
7.14 Mission Therapeutics
  7.14.1 Mission Therapeutics Corporate Summary
  7.14.2 Mission Therapeutics Business Overview
  7.14.3 Mission Therapeutics Targeted Protein Degradation Major Product Offerings
  7.14.4 Mission Therapeutics Targeted Protein Degradation Revenue in Global (2016-2021)
  7.14.5 Mission Therapeutics Key News
7.15 Novartis AG
  7.15.1 Novartis AG Corporate Summary
  7.15.2 Novartis AG Business Overview
  7.15.3 Novartis AG Targeted Protein Degradation Major Product Offerings
  7.15.4 Novartis AG Targeted Protein Degradation Revenue in Global (2016-2021)
  7.15.5 Novartis AG Key News
7.16 Pfizer Inc
  7.16.1 Pfizer Inc Corporate Summary
  7.16.2 Pfizer Inc Business Overview
  7.16.3 Pfizer Inc Targeted Protein Degradation Major Product Offerings
  7.16.4 Pfizer Inc Targeted Protein Degradation Revenue in Global (2016-2021)
  7.16.5 Pfizer Inc Key News
7.17 Promega
  7.17.1 Promega Corporate Summary
  7.17.2 Promega Business Overview
  7.17.3 Promega Targeted Protein Degradation Major Product Offerings
  7.17.4 Promega Targeted Protein Degradation Revenue in Global (2016-2021)
  7.17.5 Promega Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Targeted Protein Degradation Market Opportunities & Trends in Global Market
Table 2. Targeted Protein Degradation Market Drivers in Global Market
Table 3. Targeted Protein Degradation Market Restraints in Global Market
Table 4. Key Players of Targeted Protein Degradation in Global Market
Table 5. Top Targeted Protein Degradation Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Targeted Protein Degradation Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Targeted Protein Degradation Revenue Share by Companies, 2016-2021
Table 8. Global Companies Targeted Protein Degradation Product Type
Table 9. List of Global Tier 1 Targeted Protein Degradation Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Protein Degradation Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Targeted Protein Degradation Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Targeted Protein Degradation Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Targeted Protein Degradation Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Targeted Protein Degradation Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Targeted Protein Degradation Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Targeted Protein Degradation Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Targeted Protein Degradation Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Targeted Protein Degradation Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Targeted Protein Degradation Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Targeted Protein Degradation Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Targeted Protein Degradation Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Targeted Protein Degradation Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Targeted Protein Degradation Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Targeted Protein Degradation Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Targeted Protein Degradation Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Targeted Protein Degradation Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Targeted Protein Degradation Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Targeted Protein Degradation Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Targeted Protein Degradation Revenue, (US$, Mn), 2022-2027
Table 30. 5AM Venture Management LLC Corporate Summary
Table 31. 5AM Venture Management LLC Targeted Protein Degradation Product Offerings
Table 32. 5AM Venture Management LLC Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 33. AbbVie Inc Corporate Summary
Table 34. AbbVie Inc Targeted Protein Degradation Product Offerings
Table 35. AbbVie Inc Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 36. Almac Group Corporate Summary
Table 37. Almac Group Targeted Protein Degradation Product Offerings
Table 38. Almac Group Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 39. Amgen Inc. Corporate Summary
Table 40. Amgen Inc. Targeted Protein Degradation Product Offerings
Table 41. Amgen Inc. Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 42. Bayer AG Corporate Summary
Table 43. Bayer AG Targeted Protein Degradation Product Offerings
Table 44. Bayer AG Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 45. Biogen Inc. Corporate Summary
Table 46. Biogen Inc. Targeted Protein Degradation Product Offerings
Table 47. Biogen Inc. Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 48. C4 Therapeutics Corporate Summary
Table 49. C4 Therapeutics Targeted Protein Degradation Product Offerings
Table 50. C4 Therapeutics Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 51. Cosmo Bio USA Corporate Summary
Table 52. Cosmo Bio USA Targeted Protein Degradation Product Offerings
Table 53. Cosmo Bio USA Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 54. Covance Inc Corporate Summary
Table 55. Covance Inc Targeted Protein Degradation Product Offerings
Table 56. Covance Inc Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 57. Eli Lilly and Company Corporate Summary
Table 58. Eli Lilly and Company Targeted Protein Degradation Product Offerings
Table 59. Eli Lilly and Company Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 60. Gilead Sciences, Inc Corporate Summary
Table 61. Gilead Sciences, Inc Targeted Protein Degradation Product Offerings
Table 62. Gilead Sciences, Inc Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 63. GlaxoSmithKline plc Corporate Summary
Table 64. GlaxoSmithKline plc Targeted Protein Degradation Product Offerings
Table 65. GlaxoSmithKline plc Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 66. Merck KGaA Corporate Summary
Table 67. Merck KGaA Targeted Protein Degradation Product Offerings
Table 68. Merck KGaA Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 69. Mission Therapeutics Corporate Summary
Table 70. Mission Therapeutics Targeted Protein Degradation Product Offerings
Table 71. Mission Therapeutics Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 72. Novartis AG Corporate Summary
Table 73. Novartis AG Targeted Protein Degradation Product Offerings
Table 74. Novartis AG Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 75. Pfizer Inc Corporate Summary
Table 76. Pfizer Inc Targeted Protein Degradation Product Offerings
Table 77. Pfizer Inc Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)
Table 78. Promega Corporate Summary
Table 79. Promega Targeted Protein Degradation Product Offerings
Table 80. Promega Targeted Protein Degradation Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Targeted Protein Degradation Segment by Type
Figure 2. Targeted Protein Degradation Segment by Application
Figure 3. Global Targeted Protein Degradation Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Targeted Protein Degradation Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Targeted Protein Degradation Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Targeted Protein Degradation Revenue in 2020
Figure 8. By Type - Global Targeted Protein Degradation Revenue Market Share, 2016-2027
Figure 9. By Application - Global Targeted Protein Degradation Revenue Market Share, 2016-2027
Figure 10. By Region - Global Targeted Protein Degradation Revenue Market Share, 2016-2027
Figure 11. By Country - North America Targeted Protein Degradation Revenue Market Share, 2016-2027
Figure 12. US Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Targeted Protein Degradation Revenue Market Share, 2016-2027
Figure 16. Germany Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 17. France Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Targeted Protein Degradation Revenue Market Share, 2016-2027
Figure 24. China Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 28. India Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Targeted Protein Degradation Revenue Market Share, 2016-2027
Figure 30. Brazil Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Targeted Protein Degradation Revenue Market Share, 2016-2027
Figure 33. Turkey Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Targeted Protein Degradation Revenue, (US$, Mn), 2016-2027
Figure 37. 5AM Venture Management LLC Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AbbVie Inc Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Almac Group Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Amgen Inc. Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Bayer AG Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Biogen Inc. Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. C4 Therapeutics Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Cosmo Bio USA Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Covance Inc Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Eli Lilly and Company Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Gilead Sciences, Inc Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. GlaxoSmithKline plc Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Merck KGaA Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Mission Therapeutics Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Novartis AG Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Pfizer Inc Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Promega Targeted Protein Degradation Revenue Year Over Year Growth (US$, Mn) & (2016-2021)